29
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Snail1-expressing fibroblasts in the tumor microenvironment display mechanical properties that support metastasis.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Crosstalk between tumor and stromal cells in the tumor microenvironment alter its properties in ways that facilitate the invasive behavior of tumor cells. Here, we demonstrate that cancer-associated fibroblasts (CAF) increase the stiffness of the extracellular matrix (ECM) and promote anisotropic fiber orientation, two mechanical signals generated through a Snail1/RhoA/αSMA-dependent mechanism that sustains oriented tumor cell migration and invasiveness. Snail1-depleted CAF failed to acquire myofibroblastic traits in response to TGFβ, including RhoA activation, αSMA-positive stress fibers, increased fibronectin fibrillogenesis, and production of a stiff ECM with oriented fibers. Snail1 expression in human tumor-derived CAF was associated with an ability to organize the ECM. In coculture, a relatively smaller number of Snail1-expressing CAF were capable of imposing an anisotropic ECM architecture, compared with nonactivated fibroblasts. Pathologically, human breast cancers with Snail1(+) CAF tended to exhibit desmoplastic areas with anisotropic fibers, lymph node involvement, and poorer outcomes. Snail1 involvement in driving an ordered ECM was further confirmed in wound-healing experiments in mice, with Snail1 depletion preventing the anisotropic organization of granulation tissue and delaying wound healing. Overall, our results showed that inhibiting Snail1 function in CAF could prevent tumor-driven ECM reorganization and cancer invasion.

          Related collections

          Author and article information

          Journal
          Cancer Res.
          Cancer research
          1538-7445
          0008-5472
          Jan 15 2015
          : 75
          : 2
          Affiliations
          [1 ] Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain.
          [2 ] Department of Medical Oncology, Puerta de Hierro Majadahonda University Hospital, Majadahonda, Madrid, Spain.
          [3 ] Unitat de Biofísica i Bioenginyeria, Universitat de Barcelona, Barcelona, Spain. Institute for Bioengineering of Catalonia, Barcelona, Spain.
          [4 ] Department of Oncology and Hematology, Hospital Clínico Universitario, Valencia, Spain. Department of Medicine, Valencia Central University, Valencia, Spain.
          [5 ] Molecular Therapeutics and Biomarkers in Cancer Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain. Medical Oncology Department, Hospital del Mar, Barcelona, Spain. Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
          [6 ] Molecular Therapeutics and Biomarkers in Cancer Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain. Medical Oncology Department, Hospital del Mar, Barcelona, Spain.
          [7 ] Unitat de Biofísica i Bioenginyeria, Universitat de Barcelona, Barcelona, Spain. Institute for Bioengineering of Catalonia, Barcelona, Spain. Ciber Enfermedades Respiratorias (CIBERES), 07110-Bunyola, Spain.
          [8 ] Molecular Therapeutics and Biomarkers in Cancer Laboratory, Institut Hospital del Mar d'Investigacions Mèdiques, Hospital del Mar, Barcelona, Spain. Department of Pathology, IIS-Fundación Jiménez Díaz, Madrid, Spain. Department of Pathology, Hospital del Mar, Barcelona, Spain.
          [9 ] Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain. Departament de Ciències Experimentals i de la Salut, Universitat Pompeu Fabra, Barcelona, Spain.
          [10 ] Programa de Recerca en Càncer, Institut Hospital del Mar d'Investigacions Mèdiques, Barcelona, Spain. jbaulida@imim.es.
          Article
          0008-5472.CAN-14-1903
          10.1158/0008-5472.CAN-14-1903
          25488750
          f66a99e3-806d-4f8d-b4b4-44bf3551f0ee
          ©2014 American Association for Cancer Research.
          History

          Comments

          Comment on this article